Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Change in Taxes (2016 - 2025)

Iradimed (IRMD) has disclosed Change in Taxes for 13 consecutive years, with -$28437.0 as the latest value for Q3 2025.

  • On a quarterly basis, Change in Taxes fell 179.1% to -$28437.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$743289.0, a 921.63% decrease, with the full-year FY2024 number at -$786051.0, down 4108.43% from a year prior.
  • Change in Taxes was -$28437.0 for Q3 2025 at Iradimed, up from -$421762.0 in the prior quarter.
  • In the past five years, Change in Taxes ranged from a high of $3.2 million in Q3 2022 to a low of -$876498.0 in Q4 2024.
  • A 5-year average of $127218.9 and a median of $18.0 in 2023 define the central range for Change in Taxes.
  • Peak YoY movement for Change in Taxes: surged 6985.8% in 2022, then tumbled 4869533.33% in 2024.
  • Iradimed's Change in Taxes stood at $459062.0 in 2021, then tumbled by 163.66% to -$292260.0 in 2022, then skyrocketed by 100.01% to $18.0 in 2023, then crashed by 4869533.33% to -$876498.0 in 2024, then surged by 96.76% to -$28437.0 in 2025.
  • Per Business Quant, the three most recent readings for IRMD's Change in Taxes are -$28437.0 (Q3 2025), -$421762.0 (Q2 2025), and $583408.0 (Q1 2025).